Filter
660
Filtered Results: 660
Text search:
interpretation
primer
Featured
Recommendations
60
New Publications
125
Language
Document type
No document type
267
Guidelines
172
Studies & Reports
95
Manuals
71
Strategic & Response Plan
33
Training Material
12
Fact sheets
8
Brochures
1
Resource Platforms
1
Countries / Regions
Latin America and the Carribbean
77
Colombia
29
Global
28
Argentina
26
Paraguay
22
India
22
Venezuela
16
Ecuador
14
Bolivia
12
Peru
9
El Salvador
7
Chile
6
Africa
5
Spain
5
Guatemala
5
Mexico
4
South–East Asia Region
4
Western and Central Europe
4
Honduras
4
Kenya
3
Philippines
3
Tanzania
3
Uruguay
3
Nicaragua
3
Ethiopia
3
Nepal
2
Cameroon
2
Asia
2
Brazil
2
Indonesia
2
Myanmar / Burma
2
North Korea
1
Timor Leste/ East Timor
1
Thailand
1
Syria
1
Senegal
1
Burkina Faso
1
Zimbabwe
1
Guinea
1
USA
1
Dominican Republic
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Bangladesh
1
South Africa
1
Eastern Europe
1
Sri Lanka
1
Central African Republic
1
Bhutan
1
Liberia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
207
Clinical Guidelines
78
Public Health
53
Women & Child Health
36
Key Resources
30
Pharmacy & Technologies
26
Capacity Building
5
Toolboxes
COVID-19
80
TB
72
Mental Health
62
NTDs
43
HIV
32
Rapid Response
30
Planetary Health
27
Zika
27
Disability
26
AMR
25
Caregiver
23
Malaria
14
Global Health Education
11
Pharmacy
10
Natural Hazards
8
Conflict
7
Refugee
6
Ebola & Marburg
6
Social Ethics
6
NCDs
5
Cholera
4
Health Financing Toolbox
3
Polio
3
Specific Hazards
2
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10...
Update 2021; Immunization, Vaccines and Biologicals
Technical and operational ‘how-to’: practical considerations
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, implementers and managers of maternal, newborn and chil...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
Adolescence is a critical stage in life for physical, cognitive and emotional development, shaping future health and well-being. Comprehensive measurement of adolescent health is essential to prioritize health issues, guide interventions and track progress. However, global, regional and national ado...
Training module on malaria control
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Copenhagen, Denmark, 24–25 August 2017
Trachoma is the leading infectious cause of blindness worldwide. In April 2023, it was a public health problem
in approximately 40 countries, with an estimated 116 million people at risk and 1.5 million people affected
by the late blinding stage of the disease (1). About 84% of those at risk of tr...
Policy framework.
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
Operational Guidelines
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
